Literature DB >> 22783398

Correlation of histone methyl marks with circulating nucleosomes in blood plasma of cancer patients.

Ugur Gezer1, Ufuk Mert, Emre Ozgür, Ebru E Yörüker, Stefan Holdenrieder, Nejat Dalay.   

Abstract

Circulating DNA is present in plasma/serum, mainly complexed with histones as nucleosomes. The detection of circulating nucleosomes (cNUCs) in the peripheral blood may be a diagnostic modality for cancer-associated changes of modified histone tails in blood circulation. In the present study, we investigated the correlation between the trimethylation of H3 lysine 9 (H3K9me3) and H4 lysine 20 (H4K20me3), which are hallmarks of pericentric heterochromatin, and cNUCs in healthy subjects and patients with colorectal cancer (CRC) and multiple myeloma (MM). The plasma concentration of cNUCs was measured using the Cell-Death Detection ELISA kit. Histone methylation marks were detected using chromatin immunoprecipitation (ChIP), followed by quantitative PCR with pericentric satellite 2 as the target sequence. The results showed a high variation in the concentrations of cNUCs, with healthy subjects exhibiting the lowest levels (median 0.194), the CRC patients intermediate (median 0.25) and the MM patients the highest levels (median 0.648). However, the differences between the groups did not reach statistical significance (p>0.05). Analysis using the Pearson's correlation test revealed a significant positive correlation between the concentration of cNUCs and H3K9me3 and H4K20me3 in the whole study group (N=57, p<0.001 for both histone marks). A study of the correlation between cNUCs and histone marks in the individual study groups demonstrated the correlation between cNUCs and H3K9me3 in CRC patients to be weak (p=0.046), indicating that circulating H3K9me3 may be modified in CRC patients. The histone marks were normalized using the values of cNUCs. In agreement with the weak correlation between cNUCs and H3K9me3 in CRC patients, H3K9me3 levels (median 0.047) were lowest in this group compared with the other two groups (0.06 in healthy subjects, 0.2 in MM patients, p = not significant). For H4K20me3, the median values were 0.022 in healthy subjects, 0.052 in CRC patients and 0.056 in MM patients. In conclusion, our findings indicate a marked correlation between cNUCs and histone methyl marks.

Entities:  

Year:  2012        PMID: 22783398      PMCID: PMC3389626          DOI: 10.3892/ol.2012.600

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  14 in total

1.  Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer.

Authors:  Stefan Holdenrieder; Petra Stieber; Joachim von Pawel; Hannelore Raith; Dorothea Nagel; Knut Feldmann; Dietrich Seidel
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

Review 2.  Studying histone modifications and their genomic functions by employing chromatin immunoprecipitation and immunoblotting.

Authors:  Ranveer S Jayani; Praveena L Ramanujam; Sanjeev Galande
Journal:  Methods Cell Biol       Date:  2010       Impact factor: 1.441

3.  Nucleosomes in colorectal cancer patients during radiochemotherapy.

Authors:  Andreas Kremer; Stefan Holdenrieder; Petra Stieber; Ralf Wilkowski; Dorothea Nagel; Dietrich Seidel
Journal:  Tumour Biol       Date:  2006-07-19

4.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

Authors:  S Jahr; H Hentze; S Englisch; D Hardt; F O Fackelmayer; R D Hesch; R Knippers
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

5.  Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls.

Authors:  Julia Beck; Howard B Urnovitz; William M Mitchell; Ekkehard Schütz
Journal:  Mol Cancer Res       Date:  2010-03-09       Impact factor: 5.852

6.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer.

Authors:  Mario F Fraga; Esteban Ballestar; Ana Villar-Garea; Manuel Boix-Chornet; Jesus Espada; Gunnar Schotta; Tiziana Bonaldi; Claire Haydon; Santiago Ropero; Kevin Petrie; N Gopalakrishna Iyer; Alberto Pérez-Rosado; Enrique Calvo; Juan A Lopez; Amparo Cano; Maria J Calasanz; Dolors Colomer; Miguel Angel Piris; Natalie Ahn; Axel Imhof; Carlos Caldas; Thomas Jenuwein; Manel Esteller
Journal:  Nat Genet       Date:  2005-03-13       Impact factor: 38.330

7.  Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.

Authors:  Enders K O Ng; Nancy B Y Tsui; Nicole Y L Lam; Rossa W K Chiu; Simon C H Yu; S C Cesar Wong; Elena S F Lo; Timothy H Rainer; Philip J Johnson; Y M Dennis Lo
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

Review 8.  Clinical use of circulating nucleosomes.

Authors:  Stefan Holdenrieder; Petra Stieber
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

9.  Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls.

Authors:  M B Giacona; G C Ruben; K A Iczkowski; T B Roos; D M Porter; G D Sorenson
Journal:  Pancreas       Date:  1998-07       Impact factor: 3.327

10.  Chromatin immunoprecipitation: optimization, quantitative analysis and data normalization.

Authors:  Max Haring; Sascha Offermann; Tanja Danker; Ina Horst; Christoph Peterhansel; Maike Stam
Journal:  Plant Methods       Date:  2007-09-24       Impact factor: 4.993

View more
  7 in total

Review 1.  Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?

Authors:  Shafqat Ali Khan; Divya Reddy; Sanjay Gupta
Journal:  World J Biol Chem       Date:  2015-11-26

Review 2.  Pathologists and liquid biopsies: to be or not to be?

Authors:  Paul Hofman; Helmut H Popper
Journal:  Virchows Arch       Date:  2016-08-23       Impact factor: 4.064

Review 3.  Challenges of deciphering gastric cancer heterogeneity.

Authors:  Petra Hudler
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 4.  "Liquid biopsy"-ctDNA detection with great potential and challenges.

Authors:  Mingwei Ma; Hongcheng Zhu; Chi Zhang; Xinchen Sun; Xianshu Gao; Gang Chen
Journal:  Ann Transl Med       Date:  2015-09

5.  Quantitative detection of circulating nucleophosmin mutations DNA in the plasma of patients with acute myeloid leukemia.

Authors:  Jing Quan; Yu-jie Gao; Zai-lin Yang; Hui Chen; Jing-rong Xian; Shuai-shuai Zhang; Qin Zou; Ling Zhang
Journal:  Int J Med Sci       Date:  2015-01-01       Impact factor: 3.738

6.  Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer.

Authors:  Ugur Gezer; Ebru E Yörüker; Metin Keskin; Cemil Burak Kulle; Yoganiranjana Dharuman; Stefan Holdenrieder
Journal:  Int J Mol Sci       Date:  2015-12-11       Impact factor: 5.923

7.  Creation of a federated database of blood proteins: a powerful new tool for finding and characterizing biomarkers in serum.

Authors:  John Marshall; Peter Bowden; Jean Claude Schmit; Fay Betsou
Journal:  Clin Proteomics       Date:  2014-01-29       Impact factor: 3.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.